Back to search
FDAFDA · Food and drugs·Recall number D-0511-2024

Tirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial, Rx only, This is a Compounded Product By: Revive RX Pharmacy, 3831 Golf Dr A, Houston, TX 77018, internally assigned NDC 99000-9278-64

Published June 5, 2024 · Recall initiated: April 20, 2024

Summary

FDA records drug Class I recall D-0511-2024, published June 5, 2024 and initiated April 20, 2024. Recalling firm: Revive Rx LLC dba Revive Rx Pharmacy; Status: Ongoing; Reported quantity: 751 vials; Lot: Lot #: 748127, Exp 9/24/2024. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionate

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Revive Rx LLC dba Revive Rx Pharmacy
Distributor
USA Nationwide
Lot
Lot #: 748127, Exp 9/24/2024
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Tirzepatide 10 mg/0.5 mL Sterile Solution, 2 mL Multi-dose vial, Rx only, This is a Compounded Product By: Revive RX Pharmacy, 3831 Golf Dr A, Houston, TX 77018, internally assigned NDC 99000-9278-64 recalled?

Yes. FDA published recall D-0511-2024 on June 5, 2024. Reported hazard: Labeling: Label Mix-up - product labeled as tirzepatide contains testosterone cypionate

What should I do if I have this product?

Voluntary: Firm initiated · Telephone